Press Releases
On behalf of nearly 100 million Americans affected by liver disease, we applaud the reintroduction of the Living Donor Protection Act of 2023.
ALF will become the first liver organization to join AST’s Living Donor Circle of Excellence and become a strategic partner.
Read how this year’s marathon is extra special for two marathoners running for their dad who will receive a life-saving liver transplant!
April is Donate Life Month and American Liver Foundation (ALF) is encouraging everyone to learn how to become or find a living organ donor.
The American Liver Foundation (ALF) has begun hosting its annual Liver Life Walks for 2023. There will be 17 in-person walks across the country and one virtual walkheld this year.
Emmanuel Thomas, MD, PhD of University of Miami School of Medicine to lead national board of directors.
A two-day virtual event on March 15th and 16th will bring together key stakeholders with one goal in mind—find solutions to improve health outcomes for all those suffering from rare autoimmune liver diseases.
We applaud President Biden's budget proposal to expand hepatitis C screening, testing, treatment, prevention, and monitoring. We urge the Administration to take similar action for NAFLD.
We’re proud to launch our new Pediatric Liver Disease Information Center. Find disease specific information, patient stories, videos, activities, educational resources and more! Access the online site as a parent, teen or child to view age-appropriate information.
The American Liver Foundation (ALF) is pleased to announce the winner of its 2022 Distinguished Scientific Achievement Award, David E. Cohen, MD, PhD of Brigham and Women’s Hospital, Boston, MA.
The American Liver Foundation (ALF) is proud to once again be a member of the TCS New York City Marathon Official Charity Program for the 2022 race, which takes place on Sunday, November 6, 2022, in New York City’s five boroughs.
This one-day virtual program brings together hundreds of leading biomedical scientists and physicians from across the globe and is designed to bridge the remarkable advances in basic biology and engineering with the understanding of liver diseases and their treatment.